Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target-Reference-Cited by-同舟云学术

Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target

Published:2010-12 Issue:12 Volume:95 Page:5338-5347
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Marlow Laura A.,D'Innocenzi Jaclyn,Zhang Yilin,Rohl Stephen D.,Cooper Simon J.,Sebo Thomas,Grant Clive,McIver Bryan,Kasperbauer Jan L.,Wadsworth J. Trad,Casler John D.,Kennedy Pamela W.,Highsmith W. Edward,Clark Orlo,Milosevic Dragana,Netzel Brian,Cradic Kendall,Arora Shilpi,Beaudry Christian,Grebe Stefan K.,Silverberg Marc L.,Azorsa David O.,Smallridge Robert C.,Copland John A.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge mapping of anaplastic thyroid cancer treatments: a bibliometric analysis (2000-2023);Frontiers in Oncology;2024-02-14

2. Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer;Thyroid®;2024-01-16

3. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;Frontiers in Endocrinology;2023-10-26

4. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;2023-06-07

5. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity;Endocrine-Related Cancer;2023-03-20